Pharmacists in Arlington Heights, Illinois


60 Pharmacists found in Arlington Heights
female pharmacist

Shirley Peters, PHARMD


Pharmacist
235 E Palatine Rd, Arlington Heights, IL 60004
847-394-2420    

male pharmacist

Siby Mathew


Pharmacist
1711 W Campbell St, Arlington Heights, IL 60005
847-577-7099    

female pharmacist

Silvana Bebawy


Pharmacist
800 W Central Rd, Arlington Heights, IL 60005
312-399-0565    



female pharmacist

Sunita J Patel, PHARMD


Pharmacist
1700 E Rand Rd, T-1176, Arlington Heights, IL 60004
847-222-1750     847-222-1750

female pharmacist

Mrs. Susan F. Michaelis, RPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
405 W South St, Arlington Heights, IL 60005
847-253-6422    

female pharmacist

Suzanne Danielle Salutric, PHARMD


Pharmacist
3 E Golf Rd, Arlington Heights, IL 60005
708-738-1840    

male pharmacist

Timothy James Sassack, PHARMD


Pharmacist
235 E Palatine Rd, Arlington Heights, IL 60004
847-394-2420    

female pharmacist

Dr. Tina Park, PHARMD


Pharmacist
3 E. Golf Road, Arlington Heights, IL 60005
847-593-6650    

male pharmacist

Dr. Vikramjeet Singh, PHARMD


Pharmacist
442 E Rand Rd, Arlington Heights, IL 60004
847-255-8740    

male pharmacist

Vimal Patel, PHARM D.


Pharmacist
1711 W Campbell St, Arlington Heights, IL 60005
847-577-7099     847-577-7316

male pharmacist

Mr. William A Nelson, R.PH.


Pharmacist
973 W Essex Pl, Arlington Heights, IL 60004
847-255-1718    

male pharmacist

William A Harris, RPH


Pharmacist - Geriatric
20 S Dunton Ave, Arlington Heights, IL 60005
847-259-1450     847-259-1481


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.